BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10151136)

  • 1. Down the road to product analysis, step by step. Medical Alley's Cost-Effectiveness Task Force.
    Mater Manag Health Care; 1995 Sep; 4(9):24. PubMed ID: 10151136
    [No Abstract]   [Full Text] [Related]  

  • 2. What price progress? Technology assessment teams field requests--and politics.
    Taylor KS
    Health Facil Manage; 1995 Feb; 8(2):20, 22-4. PubMed ID: 10139798
    [No Abstract]   [Full Text] [Related]  

  • 3. OR technology decisions shift to outcomes.
    Patterson P
    OR Manager; 1995 Apr; 11(4):16, 20. PubMed ID: 10141576
    [No Abstract]   [Full Text] [Related]  

  • 4. A primer on the assessment of medical technologies.
    Matuszewski KA
    Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing new mechanical ventilation technology: the hospital perspective.
    Kacmarek RM
    Respir Care; 1995 Sep; 40(9):947-51. PubMed ID: 10152238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing the product standardization process.
    Mauro C
    J Healthc Resour Manag; 1995 Mar; 13(3):20-2, 24-5. PubMed ID: 10154862
    [No Abstract]   [Full Text] [Related]  

  • 7. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology assessment and equipment management: a practical approach to cost reduction.
    Franklin JD; Altman D
    J Healthc Resour Manag; 1996; 14(6):16-9. PubMed ID: 10159337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NICE's use of cost effectiveness as an exemplar of a deliberative process.
    Culyer AJ
    Health Econ Policy Law; 2006 Jul; 1(Pt 3):299-318. PubMed ID: 18634698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology assessment at work: Part I--Principles and a case study.
    Cowan J; Berkowitz D
    Physician Exec; 1996 Apr; 22(4):5-6, 8-9. PubMed ID: 10156730
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of cost-effectiveness analysis in health care decision-making.
    Magel JS
    Physician Exec; 1990; 16(3):31-2. PubMed ID: 10113233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A physician-led value analysis process.
    Christofanelli C; Vautrain R
    OR Manager; 2007 Jun; 23(6):16-7. PubMed ID: 17612340
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of clinical effects.
    Teerawattananon Y; Thavorncharoensap M; Mohara A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making health technology assessment information available for decision making: the development of a Thai database.
    Kapol N; Maitreemit P; Chalongsuk R; Amrumpai Y; Sribundit N; Thavorncharoensap M; Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S8-10. PubMed ID: 19253482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care technology adoption and diffusion in a social context.
    Coyte PC; Holmes D
    Policy Polit Nurs Pract; 2007 Feb; 8(1):47-54. PubMed ID: 17470771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond tech assessment: balancing needs, strategy.
    Lumsdon K
    Hospitals; 1992 Aug; 66(15):20-6. PubMed ID: 1639365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lasso runaway technology and supply chain costs.
    Wilson D; Kumor R; Bar AH
    Nurs Manage; 2007 May; 38(5):24-30. PubMed ID: 17486010
    [No Abstract]   [Full Text] [Related]  

  • 20. Technology assessment and cost-effectiveness analysis: misguided guidelines?
    Naylor CD; Williams JI; Basinski A; Goel V
    CMAJ; 1993 Mar; 148(6):921-4. PubMed ID: 8448706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.